Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.56 |
| ▸ | GBA1 | P04062 | 12/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18493347 | 1.00 | HRH4 (0.56) | HRH4HRH3GBA1EPHX2CYP19A1 | |
| SCHEMBL18494157 | 1.00 | HRH4 (0.56) | HRH4HRH3GBA1EPHX2CYP19A1 | |
| SCHEMBL18489275 | 1.00 | HRH4 (0.56) | HRH4HRH3GBA1EPHX2CYP19A1 | |
| SCHEMBL19300362 | 1.00 | HRH4 (0.56) | HRH4HRH3GBA1EPHX2CYP19A1 | |
| SCHEMBL19479091 | 1.00 | HRH4 (0.56) | HRH4HRH3GBA1EPHX2CYP19A1 | |
| SCHEMBL3536093 | 0.99 | HRH4 (0.55) | HRH4HRH3GBA1EPHX2CYP19A1 | |
| SCHEMBL12265820 | 0.99 | HRH4 (0.55) | HRH4HRH3GBA1EPHX2CYP19A1 | |
| SCHEMBL23918008 | 0.96 | GBA1 (0.53) | HRH4HRH3GBA1EPHX2CYP19A1 | |
| SCHEMBL21671071 | 0.96 | GBA1 (0.53) | HRH4HRH3GBA1EPHX2CYP19A1 | |
| SCHEMBL5021139 | 0.96 | HRH4 (0.54) | HRH4HRH3GBA1EPHX2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200384085-A1 | PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2020-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200384085-A1 | PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | APLNR, SCTR, GIPR | HRH4 1253/4885HRH3 1725/4885GBA1 1277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.